Efficacy of Dose Escalation of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Medical Principles and Practice · 03.02.2025 · 34 (3) · 226-237
DOI: 10.1159/000543831 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medical Principles and Practice, online erschienen am 03.02.2025. Verfasst von Mohammad Ebad Ur Rehman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: Ustekinumab, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Ustekinumab is an effective drug in the treatment of inflammatory bowel disease (IBD), but inadequate response or loss of response is reported in several patients. Dose escalation by intravenous reinduction or interval shortening may be a suitable option to recapture response. We undertook a systematic review and meta-analysis to assess the efficacy of dose escalation in IBD patients receiving ustekinumab.
Methods
A systematic literature search was conducted on PubMed, Embase, Clinicaltrails.gov, and Cochrane from inception to June 1, 2024. We conducted a proportional meta-analysis on MetaXL. Our primary outcomes were clinical response and clinical remission.
Results
Twenty-eight articles were included (n = 2,129 patients). Eighteen studies (692 patients out of 1,218) reported clinical response, with pooled prevalence of 55% (95% CI: 46–65%). Out of 1,041 patients, 524 showed clinical remission with pooled prevalence of 51% (95% CI: 42–59%).
Conclusion
This systematic review and meta-analysis showcased promising results, in terms of clinical response and remission, in IBD patients receiving dose escalation of ustekinumab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
- Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
- Department of Medicine, Khyber Medical College, Peshawar, Pakistan.
- Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.
- Department of Medicine, Saidu Medical College, Swat, Pakistan.
- Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Zitieren
APA
Rehman, M. E. U., Tahir, A., Hussain, A., Ali, A., Bin Gulzar, A. H., Khan, A. Q., Sajjad, M., Shahid, F., Zahid, S., Aslam, U., Yasin, T. B., Bilal, A., Fatima, T., Hameed, M. S., Haider, T., Saeed, S., & Nashwan, A. J. (2025). Efficacy of Dose Escalation of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Medical Principles and Practice, 34(3), 226-237. https://doi.org/10.1159/000543831
Vancouver
Rehman MEU, Tahir A, Hussain A, Ali A, Bin Gulzar AH, Khan AQ, et al. Efficacy of Dose Escalation of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Medical Principles and Practice. 2025;34(3):226-237. doi:10.1159/000543831
BibTeX
@article{Rehman2025,
author = {Rehman, Mohammad Ebad Ur and Tahir, Ammara and Hussain, Amna and Ali, Aizaz and Bin Gulzar, Abu Huraira and Khan, Abdul Qadeer and Sajjad, Maha and Shahid, Fatima and Zahid, Shahroon and Aslam, Ummara and Yasin, Talha Bin and Bilal, Aqsa and Fatima, Tehreem and Hameed, Muhammad Sheraz and Haider, Tehseen and Saeed, Sajeel and Nashwan, Abdulqadir J},
title = {Efficacy of Dose Escalation of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis},
journal = {Medical Principles and Practice},
year = {2025},
volume = {34},
number = {3},
pages = {226--237},
doi = {10.1159/000543831}
}
EUVIMED